These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

423 related articles for article (PubMed ID: 32561657)

  • 1. Could an Unrelated Live Attenuated Vaccine Serve as a Preventive Measure To Dampen Septic Inflammation Associated with COVID-19 Infection?
    Fidel PL; Noverr MC
    mBio; 2020 Jun; 11(3):. PubMed ID: 32561657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Repurposing of the childhood vaccines: could we train the immune system against the SARS-CoV-2.
    Sharma D
    Expert Rev Vaccines; 2021 Sep; 20(9):1051-1057. PubMed ID: 34313516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaccine repurposing approach for preventing COVID 19: can MMR vaccines reduce morbidity and mortality?
    Anbarasu A; Ramaiah S; Livingstone P
    Hum Vaccin Immunother; 2020 Sep; 16(9):2217-2218. PubMed ID: 32501133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential role of Bacillus Calmette-Guérin (BCG) vaccination in COVID-19 pandemic mortality: Epidemiological and Immunological aspects.
    Charoenlap S; Piromsopa K; Charoenlap C
    Asian Pac J Allergy Immunol; 2020 Sep; 38(3):150-161. PubMed ID: 32686943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New disease old vaccine: Is recombinant BCG vaccine an answer for COVID-19?
    Gupta PK
    Cell Immunol; 2020 Oct; 356():104187. PubMed ID: 32745670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Using BCG vaccine to enhance non-specific protection of health care workers during the COVID-19 pandemic: A structured summary of a study protocol for a randomised controlled trial in Denmark.
    Madsen AMR; Schaltz-Buchholzer F; Benfield T; Bjerregaard-Andersen M; Dalgaard LS; Dam C; Ditlev SB; Faizi G; Johansen IS; Kofoed PE; Kristensen GS; Loekkegaard ECL; Mogensen CB; Mohamed L; Ostenfeld A; Oedegaard ES; Soerensen MK; Wejse C; Jensen AKG; Nielsen S; Krause TG; Netea MG; Aaby P; Benn CS
    Trials; 2020 Sep; 21(1):799. PubMed ID: 32943115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Could "trained immunity" be induced by live attenuated vaccines protect against COVID-19? Review of available evidence.
    Alsulaiman JW; Khasawneh AI; Kheirallah KA
    J Infect Dev Ctries; 2020 Sep; 14(9):957-962. PubMed ID: 33031080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biological Rationale for the Repurposing of BCG Vaccine against SARS-CoV-2.
    Glisic S; Perovic VR; Sencanski M; Paessler S; Veljkovic V
    J Proteome Res; 2020 Nov; 19(11):4649-4654. PubMed ID: 32794723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of Bacillus Calmette-Guérin (BCG) vaccination in preventing severe infectious respiratory diseases other than TB: Implications for the COVID-19 pandemic.
    Yitbarek K; Abraham G; Girma T; Tilahun T; Woldie M
    Vaccine; 2020 Sep; 38(41):6374-6380. PubMed ID: 32798142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Could BCG Vaccination Induce Protective Trained Immunity for SARS-CoV-2?
    Covián C; Retamal-Díaz A; Bueno SM; Kalergis AM
    Front Immunol; 2020; 11():970. PubMed ID: 32574258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BCG vaccine may generate cross-reactive T cells against SARS-CoV-2: In silico analyses and a hypothesis.
    Tomita Y; Sato R; Ikeda T; Sakagami T
    Vaccine; 2020 Sep; 38(41):6352-6356. PubMed ID: 32863070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reactogenicity and immunogenicity of a live attenuated tetravalent measles-mumps-rubella-varicella (MMRV) vaccine.
    Nolan T; McIntyre P; Roberton D; Descamps D
    Vaccine; 2002 Dec; 21(3-4):281-9. PubMed ID: 12450703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Revisiting the potential role of BCG and MMR vaccines in COVID-19.
    Bayram Z; Musharrafieh U; Bizri AR
    Sci Prog; 2022; 105(2):368504221105172. PubMed ID: 35848578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitigating Coronavirus Induced Dysfunctional Immunity for At-Risk Populations in COVID-19: Trained Immunity, BCG and "New Old Friends".
    Kleen TO; Galdon AA; MacDonald AS; Dalgleish AG
    Front Immunol; 2020; 11():2059. PubMed ID: 33013871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BCG as a game-changer to prevent the infection and severity of COVID-19 pandemic?
    Sharma AR; Batra G; Kumar M; Mishra A; Singla R; Singh A; Singh RS; Medhi B
    Allergol Immunopathol (Madr); 2020; 48(5):507-517. PubMed ID: 32653224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MMR Vaccine and Covid-19: A Myth or a Low Risk-High Reward Preventive Measure?
    Deshpande S; Balaji S
    Indian Pediatr; 2020 Aug; 57(8):773. PubMed ID: 32710535
    [No Abstract]   [Full Text] [Related]  

  • 17. Is global BCG vaccination-induced trained immunity relevant to the progression of SARS-CoV-2 pandemic?
    Gursel M; Gursel I
    Allergy; 2020 Jul; 75(7):1815-1819. PubMed ID: 32339299
    [No Abstract]   [Full Text] [Related]  

  • 18. Bacillus Calmette Guérin (BCG) vaccination use in the fight against COVID-19 - what's old is new again?
    O'Connor E; Teh J; Kamat AM; Lawrentschuk N
    Future Oncol; 2020 Jul; 16(19):1323-1325. PubMed ID: 32406253
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of MMR Vaccination to Mitigate Severe Sequelae Associated With COVID-19: Challenges and Lessons Learned.
    Noverr MC; Yano J; Hagensee ME; Lin HY; Meyaski MC; Meyaski E; Cameron J; Shellito J; Trauth A; Fidel PL
    Med Res Arch; 2023 Feb; 11(2):. PubMed ID: 37153751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunogenicity and reactogenicity of a single dose of live attenuated varicella vaccine and a booster dose of measles-mumps-rubella vaccine given concomitantly at 12 years of age.
    Parment PA; Svahn A; Rudén U; Bråkenhielm G; Storsaeter J; Akesson L; Linde A
    Scand J Infect Dis; 2003; 35(10):736-42. PubMed ID: 14606613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.